AI assistant
EXELIXIS, INC. — Director's Dealing 2025
Nov 14, 2025
30561_dirs_2025-11-13_710db30c-c96b-41f3-9191-bd1ea7602658.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2025-11-11
Reporting Person: MORRISSEY MICHAEL (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-11 | Common Stock | G | 160000 | — | Disposed | 1692856 | Indirect |
| 2025-11-12 | Common Stock | G | 101548 | — | Disposed | 1416692 | Direct |
| 2025-11-12 | Common Stock | G | 101548 | — | Acquired | 1794404 | Indirect |
| 2025-11-12 | Common Stock | G | 80000 | — | Disposed | 1714404 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 17728 | Indirect |
Footnotes
F1: On November 11, 2025, the Reporting Person gifted 160,000 shares of Exelixis, Inc. common stock ("Common Stock") to the Bombora Rise Foundation.
F2: On November 12, 2025, the Reporting Person gifted 101,548 shares of Common Stock to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
F3: Includes 1,416,692 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs") and performance-based restricted stock units ("PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each PSU represents a contingent right to receive one share of Common Stock.
F4: On November 12, 2025, the Reporting Person gifted 80,000 shares of Common Stock to a donor advised fund.
F5: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
F6: Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 10, 2025.